Multi-directional Microfluidic CED Device for Brain Drug Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Convection-enhanced delivery (CED) techniques face challenges in achieving effective drug penetration and distribution across the blood-brain barrier, particularly due to backflow issues and the poroelastic nature of brain tissue, which limits the efficacy of drug delivery for neurological disorders.
Innovation Solution
The development of microfluidic CED devices with multi-directional drug delivery capabilities and controlled fluid pressure and velocity using the venturi effect, featuring a semi-rigid or degradable scaffold with fluid delivery conduits that allow for targeted delivery of therapeutic agents, including nanoparticles and stem cells, to bypass the blood-brain barrier.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Length of moving object
If conventional CED devices with single-directional delivery are used, then device simplicity is maintained, but drug penetration distance and spatial distribution control are insufficient
Solution Approach 1:
The device segments the fluid delivery system into multiple independent conduits (first fluid delivery conduit and second fluid delivery conduit) with different orientations. Each conduit can deliver fluid in a specific direction, enabling multi-directional drug distribution while maintaining individual conduit simplicity. This segmentation allows the device to achieve extended penetration distance and controlled spatial distribution without requiring each individual component to be overly complex.
Solution Approach 2:
The invention transitions from single-directional (one-dimensional) fluid delivery to multi-directional (three-dimensional) delivery by orienting conduits at different angles relative to the longitudinal axis of the implantable device. The first conduit is oriented at a first angle and the second conduit at a second angle, creating a three-dimensional drug distribution pattern that enhances penetration distance and controls spatial distribution throughout the target tissue volume.
2Speed
If flexible microcatheter designs are used to reduce backflow, then infusion velocity is increased, but the poroelastic nature of brain tissue still causes backflow and limits penetration
Solution Approach 1:
The device divides the fluid delivery into multiple separate conduits rather than using a single flexible microcatheter. This segmentation allows each conduit to be optimized for its specific delivery direction and reduces the backflow problem by distributing the infusion load across multiple pathways, thereby maintaining reliable drug delivery even in the poroelastic brain tissue environment.
Solution Approach 2:
The device incorporates an expandable member that can transition from a compressed delivery configuration to an expanded treatment configuration. During delivery, the device is compressed to navigate tissue; once positioned, the expandable member is deployed to stabilize the conduits and maintain optimal fluid delivery dynamics, preventing backflow while enabling sustained high-velocity infusion into the target tissue.
3Duration of action of stationary object
If nanoparticles are used to reduce elimination rate, then penetration distance is extended, but nanoparticle transport is hindered by extracellular pore size
Solution Approach 1:
The device utilizes convection-enhanced delivery (CED) technology, which employs hydraulic pressure to drive fluid and nanoparticle transport through tissue. By applying controlled pressure gradients through the multi-conduit system, the device overcomes the size-matching limitation between nanoparticles and extracellular pores, enabling rapid and efficient nanoparticle delivery to the target site while maintaining extended duration of action through reduced elimination rates.
4Adaptability or versatility
If multiple separate devices are used to achieve multi-directional delivery, then delivery versatility is improved, but device complexity and insertion difficulty increase
Solution Approach 1:
The invention merges multiple fluid delivery functions into a single integrated implantable device. The device combines a first fluid delivery conduit oriented at a first angle and a second fluid delivery conduit oriented at a second angle within one unified structure, eliminating the need for multiple separate devices. This integration maintains full multi-directional delivery versatility while simplifying the insertion procedure and reducing overall device complexity.
Solution Approach 2:
The device is designed as a universal platform that can deliver fluids in multiple directions simultaneously through its multi-oriented conduit system. The single device structure incorporates both the first and second fluid delivery conduits with different orientations, enabling it to perform multiple delivery functions that would otherwise require separate devices, thereby achieving versatility without proportionally increasing complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enhances drug penetration and distribution within the brain, improving treatment outcomes for neurological disorders by minimizing backflow and optimizing spatial distribution of therapeutic agents, thereby increasing the effectiveness of drug delivery.
Implementation Method 1
devices that control fluid pressure and velocity using the venturi effect
Implementation Method 2
Transport of the infused material is dominated by convection, which enhances drug penetration into a target tissue compared with diffusion-mediated delivery or systemic delivery
Data Source
AI summary
The methods, systems, and devices disclosed herein generally involve convection-enhanced delivery of drugs to a target region within a patient. Microfluidic catheter devices are disclosed that are particularly suitable for targeted delivery of drugs via convection, including devices capable of multi-directional drug delivery, devices that control fluid pressure and velocity using the venturi effect, and devices that include conformable balloons. Methods of treating various diseases using such devices are also disclosed, including methods of treating cerebral and spinal cavernous malformations, cavernomas, and hemangiomas, methods of treating neurological diseases, methods of treatment using multiple microfluidic delivery devices, methods of treating hearing disorders, methods of spinal drug delivery using microfluidic devices, and methods of delivering stem cells and therapeutics during fetal surgery. Methods of manufacturing such devices are also disclosed.